GlaxoSmithKline Pharma Q2 net down 14.56% to Rs 98.29 crore

Tags: Companies
GlaxoSmithKline Pharmaceuticals today reported 14.56 per cent decline in net profit to Rs 98.29 crore for the quarter ended June 30 as the company continued to be impacted by the revamped price control order.

The company had reported a net profit of Rs 115.04 crore during the same period last year.

Net sales of the company increased 2.84 per cent to Rs 654.96 crore for the second quarter as compared to Rs 636.86 crore in the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

The company follows January-December financial year.

"The quarter continued to see the impact of the base effect of differential pricing cuts due to price control order, extending coverage to the National List of Essential Medicines (NLEM)," the company said.

Last year, Department of Pharmaceuticals had notified the Drugs (Prices Control) Order 2013 under which prices of 348 medicines in the NLEM have been brought under price control, thus replacing an earlier order of 1995 that regulated prices of only 74 bulk drugs.

Shares of GlaxoSmithKline Pharma were trading 0.84 per cent down at Rs 2,473.85 apiece during afternoon trade on the BSE.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • Time and tide are ripe for megaplans such as Sagarmala

    To say that India’s infrastructure is in urgent need of upgrade would be to state the obvious.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Urs Schoettli

China looks to India for balance

Almost a third of the total world population lives in ...

Zehra Naqvi

Love and its stories

People must have bread. They can live without stories. No, Hameeda, ...

Dharmendra Khandal

Tiger in urban landscape

Ranthambhore is in a no-win situation. Just a few days ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture